MUMBAI, India and WARREN, N.J., Feb. 27, 2026 /PRNewswire/ -- Cipla USA Inc. the wholly owned subsidiary of Cipla Limited(BSE: 500087; NSE: CIPLA; and hereafter referred to as "Cipla") today announced ...

Cipla USA has recalled unexpired batches of Lanreotide Injection, resulting in a temporary market shortage. The recall ...

Cipla said supplies of its key US drug Lanreotide will remain constrained after its manufacturing partner paused production following USFDA observations ...

Cipla has received the Food and Drug Administration’s blessing for lanreotide injection 120 mg/0.5 ml, 90 mg/0.3 ml, 60 mg/0.2 ml, which is the generic of somatuline depot (lanreotide) injection.

Ozempic patent expiry has triggered a fresh pharma race in India. Sun Pharma, Cipla, and Dr Reddy’s are among 7 players ...

Cipla share price fell 2.4 per cent to the day's low of ₹1,335.90 per share on the National Stock Exchange (NSE) ...

Aurobindo, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir, also CAB-LA, for HIV treatment in 133 countries, per The Hindu report. This follows ViiV ...

With many diabetes mellitus (DM) patients struggling with the challenges of multiple daily insulin injections, there is a growing need for convenient and needle-free insulin delivery ...

Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, today announces that it has entered into an agreement with Cipla Limited and Cipla USA, Inc. to settle the ...

Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy Provided by PR Newswire Feb 27, 2026, 8:28:00 AM ...